Evidence map›Paper›PMID 29987261›Full record

ArticleMolecules (Basel, Switzerland)2018

Mechanism of Two-/Four-Electron Reduction of Nitroaromatics by Oxygen-Insensitive Nitroreductases: The Role of a Non-Enzymatic Reduction Step.

Benjaminas Valiauga, Lina Misevičienė, Michelle H Rich, David F Ackerley, Jonas Šarlauskas, Narimantas Čėnas

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Engineering theFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Benjaminas ValiaugaDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania. benjaminas.valiauga@bchi.vu.lt.
Lina MisevičienėDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania. lina.miseviciene@bchi.vu.lt.
Michelle H RichSchool of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington 6140, New Zealand. michelle.rich@vuw.ac.nz.
David F AckerleySchool of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington 6140, New Zealand. david.ackerley@vuw.ac.nz.ORCID 0000-0002-6188-9902
Jonas ŠarlauskasDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania. jonas.sarlauskas@bchi.vu.lt.
Narimantas ČėnasDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania. narimantas.cenas@bchi.vu.lt.
Vilnius University · LTVictoria University of Wellington · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen-insensitive NAD(P)H:nitroreductases (NR) reduce nitroaromatics (Ar-NO₂) into hydroxylamines (Ar-NHOH) through nitroso (Ar-NO) intermediates. Ar-NO may be reduced both enzymatically and directly by reduced nicotinamide adenine dinucleotide or its phosphate NAD(P)H, however, it is unclear which process is predominant in catalysis of NRs. We found that

Indexed as

CatalysisElectronsEscherichia coliEscherichia coli ProteinsNADPNitro CompoundsNitroreductasesOxidation-ReductionOxygenSubstrate SpecificityEscherichia coli ProteinsNADPNfsA protein, E coliNitro CompoundsNitroreductasesOxygenaromatic nitrocompoundsnitroreductasereduction mechanism

Identifiers

PMID29987261
PMCPMC6100041
OpenAlexW2838212450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.